Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China:a retrospective multicenter study

分享到

作者: Huishou Fan Weida Wang Ya Zhang Jianxiang Wang Tao Cheng Lugui Qiu Xin Wang Zhongjun Xia Gang An

作者单位: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College；State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center；Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University

关键词: Multiple myeloma autologous stem cell transplantation minimal residual disease survival outcomes multicenter study

摘要: Objective: Evidence on the prognostic value of autologous stem cell transplantation and minimal residual disease dynamics of patients with newly diagnosed multiple myeloma in China is limited. Our objective in the current study was to understand the current care paradigm and outcomes of these patients.

列表公用js 卡片页统计

看了本文的还看了